FDA's Center for Tobacco Products (CTP)

advertisement
Les Weinstein
FDA’s Center for Tobacco Products (CTP): Overview of
Requirements & Advice on How to Navigate Through Them
WT North America Conference
Richmond, Virginia
May 12-14, 2015
© EAS Consulting Group, LLC
1
FDA Organization
© EAS Consulting Group, LLC
2
2
CTP Organization
Office of Center Director
(OCD)
Director
Mitch Zeller, JD
Office of Science (OS)
Director
RADM David Ashley, PhD
Office of Regulations (OR)
Director
Beverly Chernaik, JD
Office of Compliance and
Enforcement (OCE)
Director
Ann Simoneau, JD
© EAS Consulting Group, LLC
3
Office of Health
Communication and Education
(OHCE)
Director
Kathleen Crosby
3
FDA’s Regulatory Scheme for Tobacco
•
The Family Smoking Prevention and Tobacco Control Act (usually referred to as the Tobacco Control Act
(TCA)) signed into law in June 2009, granted FDA authority to regulate tobacco products.
•
FDA established the Center for Tobacco Products (CTP) to regulate the manufacture, marketing, and
distribution of tobacco products to protect public health and to reduce tobacco use.
© EAS Consulting Group, LLC
4
4
How CTP Regulates
Tobacco Products
CTP is authorized to:
•
Require tobacco product manufacturers to register
•
Establish standards for tobacco products, such as tar and nicotine levels, in an effort to reduce their
toxicity and addictiveness
•
Establish limits on sale and distribution of tobacco products
•
Require premarket review for new and modified risk tobacco products to protect the public health
CTP actions thus far:
•
Restricting access and marketing of tobacco products to youth
•
Banned cigarettes with characterizing flavors, such as candy and fruit
•
Banned brand-name tobacco sponsorship of sporting events and concerts
•
Enforcing minimum pack size of 20 cigarettes
•
Requiring companies to report to FDA on Harmful or Potentially Harmful Constituents (HPHC) in tobacco
products
© EAS Consulting Group, LLC
5
5
How CTP Regulates
Tobacco Products (cont’d)
CTP actions thus far (cont’d):
•
Educating consumers about the risks of tobacco products
•
Requiring manufacturers to seek CTP authorization before marketing a new product or making changes to existing
products
•
Established processes for new tobacco products through three separate pathways to market: Premarket Tobacco
Applications, Substantial Equivalence (SE) Reports, Modified Risk Tobacco Product (MRTP) Applications
•
Issued decisions on small number of more than 4000 SE applications
•
Prohibited use of terms that imply reduced risk (such as “light,” “mild,” or “low”) without CTP authorization as a
MRTP
•
Contracts with states to do retail inspections re: underage purchases and other violations; has issued more than 10,000
warning letters and some civil money penalties
© EAS Consulting Group, LLC
6
6
How CTP Regulates
Tobacco Products (cont’d)
•
CTP currently regulates cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco.
•
CTP has authority to regulate “tobacco products,” which are defined in part as any product “made or
derived from tobacco” that is not a “drug,” “device,” or “combination product”.
•
FDA does not currently regulate products such as e-cigarettes, cigars, pipe tobacco, waterpipe (hookah)
tobacco, and novel products like nicotine gels and certain dissolvables, unless manufacturers make
therapeutic claims. However, CTP has published a proposed regulation (the “deeming rule”) to bring these
additional tobacco products under its authority. 135,000 comments have been submitted. The final
regulation is estimated to be published in June 2015.
© EAS Consulting Group, LLC
7
7
What CTP Cannot Do
•
Use the traditional FDA “safe and effective” standard for evaluating medical products. Instead, CTP
evaluates new tobacco products based on a public health standard that considers the risks and benefits
of the tobacco product on the population as a whole, including users and nonusers
•
Ban any class of tobacco products, such as cigarettes
•
Require the reduction of nicotine yields to zero
•
Require prescriptions to purchase tobacco products
© EAS Consulting Group, LLC
8
8
CTP Offices
•
Office of the Center Director (OCD): Provides leadership, direction, management and coordination for CTP.
Also includes stakeholder relations, Ombudsman, executive secretariat.
•
Office of Science (OS): Reviews and decides on premarket tobacco product applications: Substantial
Equivalence (SE), Modified Risk Tobacco Products (MRTP), and New Tobacco Products. Relies on science
to make regulatory decisions. Conducts own research to support regulatory science; partners with other
government agencies to support research efforts; and provides funding opportunities for external research.
•
Office of Compliance and Enforcement (OCE): Ensures that distributors, importers, manufacturers, and
retailers comply with the Tobacco Control Act : inspections, investigations, monitoring and review activities.
Develops and documents evidence to support enforcement actions. Manages state and territory retail
inspection program; registration and listing, warning letters, civil money penalties. Includes Office of Small
Business Assistance to help manufacturers and retailers understand the law and regulations.
•
Office of Regulations (OR): Develops, drafts and coordinates clearance of proposed and final regulations
(which have the force and effect of law), draft and final guidances (which are FDA’s current thinking on a
topic and do not bind the agency or the public).
•
Office of Health Communication and Education (OHCE): Develops campaigns to help educate the public,
especially youth, about tobacco products, pursuant to FDA’s authority to regulate the marketing and sales of
tobacco products.
© EAS Consulting Group, LLC
9
9
Navigating the Office of Science
(OS)
•
Submissions: Submit premarket related applications (SE, MRTP, New Tobacco Products)
according to guidances and other available information specific to the type of submission.
•
OS Contact: Regulatory Health Project Manager (RHPM) will be your primary contact. RHPM and
you will be in touch by email and phone. If your RHPM is not responsive or timely, complain to
his/her supervisor/manager or CTP Ombudsman.
•
Meetings: Tobacco product manufacturers, researchers, importers, or investigators may request a
meeting (in-person or conference call) with OS to get assistance relating to research and
development of particular tobacco products. Usually a meeting request should be sent prior to filing a
tobacco product submission, but some meeting requests are sent, and accepted, during the review
of a premarket submission. Follow the procedures in the May 2012 Guidance on “Meetings with
Industry and Investigators on the Research and Development of Tobacco Products”.
•
Appeals: If you receive an adverse decision from OS (or elsewhere in CTP) you may appeal it by
using 21 CFR (Code of Federal Regulations) 10.75. Under Section 10.75, "an interested person
outside the agency may request internal agency review of a decision through the established agency
channels of supervision or review," which is appealing up the supervisory chain of command. For
example, if a division director signed a letter denying a premarket application, you could appeal up to
the OS director. If the OS director signed the letter, you could appeal up to the Center Director. For
further information, contact the CTP Ombudsman who coordinates this process for the Center.
© EAS Consulting Group, LLC
10
10
CTP OMBUDSMAN
Ella Yeargin, JD is the CTP Ombudsman
•
Investigates complaints, facilitates resolution of disputes & responds to inquiries
•
Neutral and impartial
•
Fairness
•
Confidentiality
•
Independence
Ombudsman’s 2014 Annual Report
•
Received137 contacts from: general public/consumers (63%), tobacco companies (22%), retailers
(10%), distributors (1%), trade associations (1%) and others
•
Most common subject matter: e--cigarettes (including deeming) (43%),Substantial Equivalence
(12%), retailer compliance/inspections (12%), media campaigns (7%), FDA website (4%), smoking
bans (3%), Harmful and Potentially Harmful Constituents (HPHC) (3%)
© EAS Consulting Group, LLC
11
11
Two-way Communication with CTP
•
Sign up for FDA email updates on tobacco products at
http://www.fda.gov/TobaccoProducts/ResourcesforYou/ucm176164.htm
•
Watch CTP compliance webinars
http://www.fda.gov/TobaccoProducts/ResourcesforYou/BreakTheChain/ucm220111.htm
•
Attend and sign up to speak at TPSAC (Tobacco Product Scientific Advisory Committee) meetings
http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCo
mmittee/default.htm
•
Attend and speak at, or watch and submit questions to, CTP public meetings
•
Send in written comments on proposed rules as well as on draft and final guidances
http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/
UCM314421.pdf. CTP must consider every comment received before issuing the final version.
•
Submit a Freedom of Information Act (FOIA) request for documents not on FDA’s website
http://www.fda.gov/regulatoryinformation/foi/default.htm
© EAS Consulting Group, LLC
12
12
Two-way Communication with CTP
(cont’d)
•
Tobacco Industry Inquiries: TobaccoIndustryQuestions@fda.hhs.gov
•
Small Business Industry Questions: smallbiz.tobacco@fda.hhs.gov
•
General Consumer Inquiries: AskCTP@fda.fda.gov or 877-287-1373 (9 AM to 4 PM East Coast Time)
•
Formal Correspondence: ctpexecsec@fda.hhs.gov
•
Meeting Requests: ctpexecsec@fda.hhs.gov. Include a proposed agenda and attendee list.
•
Contact the Ombudsman: CTPOmbudsman@fda.hhs.gov or call 301-796-3095
•
All written correspondence should be sent to the following address:
Center for Tobacco Products (CTP)
Document Control Center
Building 71, Room G335
10903 New Hampshire Avenue
Silver Spring MD 20993-0002
© EAS Consulting Group, LLC
13
13
Connect with CTP on
Social Media
•
Follow @FDATobacco on Twitter
•
Visit FDA on Facebook
•
Watch FDA on YouTube
•
Browse photos on Flickr
•
Subscribe to CTP RSS feeds:
Tobacco News
Tobacco Retailer Information
•
Listen to CTP podcasts
•
Learn more about tobacco regulation on the FDA Voice Blog
© EAS Consulting Group, LLC
14
14
• Questions?
© EAS Consulting Group, LLC
15
15
EAS Consulting Group, LLC
1700 Diagonal Road, Suite 750
Alexandria, VA 22314
(877) 327-9808 Toll Free
(571) 447-5500 Local
(703) 548-3270 Fax
www.easconsultinggroup.com
16
Thank You
17
Download